Assistant Attending
Memorial Sloan Kettering Cancer Center
Dr. Urvi A. Shah is an Assistant Attending in the Myeloma Service at Memorial Sloan Kettering Cancer Center (MSK) and Assistant Professor of Medicine at Weill Cornell Medicine. She completed fellowships in hematology/oncology at Montefiore Medical Center, and in cancer immunotherapy at MSK and the Parker Institute for Cancer Immunotherapy in New York. She is board certified in Internal Medicine, Hematology and Medical Oncology.
Her clinical practice includes all plasma cell disorders and her research interests include modifiable risk factors (diet, metabolism, and the microbiome) and immune therapies in cancer. She opened the first pilot nutrition trial in plasma cell disorders to date (NUTRIVENTION; NCT04920084) in 2021 that completed enrollment. She has three other NUTRIVENTION/immune therapy investigator-initiated trials (NCT05640843, NCT04497961, NCT04174196) currently enrolling. Dr. Shah has been supported by career development awards from the National Cancer Institute Paul Calabresi K12, International Myeloma Society and American Society of Hematology Scholar Award. Dr. Shah has published first author papers in prominent journals such as Blood and Clinical Cancer Research amongst others and has been an invited speaker and session chair nationally and internationally.
Disclosure information not submitted.
In-Person Workshop: Lifestyle Medicine in Cancer Care: Ready for Prime Time?
Sunday, October 27, 2024
1:00 PM – 4:00 PM ET